G01N 2333/70532
B7 molecules
Official title: B7 molecules, e.g. CD80, CD86
G01N2333/70532 (B7 molecules) appears on 122 US grants and 314 published applications in this corpus.
Search patents in G01N- Granted patents
- 122
- Published applications
- 314
- Assignees
- 170
- Inventors
- 738
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 4 |
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 1 | 1 |
| 2007 | 0 | 5 |
| 2008 | 0 | 2 |
| 2009 | 1 | 4 |
| 2010 | 2 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 3 |
| 2013 | 2 | 3 |
| 2014 | 0 | 4 |
| 2015 | 4 | 9 |
| 2016 | 3 | 25 |
| 2017 | 8 | 19 |
| 2018 | 6 | 26 |
| 2019 | 12 | 23 |
| 2020 | 11 | 25 |
| 2021 | 10 | 24 |
| 2022 | 14 | 36 |
| 2023 | 13 | 20 |
| 2024 | 10 | 19 |
| 2025 | 15 | 34 |
| 2026 | 10 | 22 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods for treating cerebral vasospasm with a PD-1 agonist2 Jun 2026US 12,644,888 B2The Johns Hopkins University
- Treatment of PD-L1-positive melanoma using an anti-PD-1 antibody5 May 2026US 12,617,850 B2Bristol-Myers Squibb Company
- Antibody binding specifically to B7—H3 and use thereof21 Apr 2026US 12,606,625 B2IntoCell, Inc.
- Anti-PD-L1 and PD-L2 antibody and derivatives and use thereof14 Apr 2026US 12,600,782 B2Biotheus Inc.
- CD80 extracellular domain Fc fusion proteins for treating PD-L1 negative tumors31 Mar 2026US 12,589,132 B2Five Prime Therapeutics, Inc.
- B7-h4 therapeutic binding molecules for the treatment of cancer1 Oct 2026US 2026/0295065 A1MedImmune, LLC
- Anti-pd-l1 nanobody, preparation method therefor and use thereof1 Oct 2026US 2026/0297195 A1Kanglitai Biomedical (Qingdao) Co., Ltd.
- Method and kit for the diagnosis of oral carcinoma17 Sep 2026US 2026/0276642 A1
- Combination therapies involving claudin 18.2 antagonists for treatment of cancer10 Sep 2026US 2026/0265370 A1Suzhou Transcenta Therapeutics Co., Ltd.
- Compositions and methods for treating cerebral vasospasm10 Sep 2026US 2026/0266819 A1
Most cited
By later US patents
- Methods for screening for compounds that modulate pd-1 signaling113US 7,105,328 B2Dana-Farber Cancer Institute, Inc. · 2006
- Agents that modulate the interaction of B7-1 polypeptide with PD-L1 and methods of use thereof80US 7,722,868 B2Dana-Farber Cancer Institute, Inc. · 2010
- B7-H1 Antibodies71US 8,981,063 B2Mayo Foundation for Medical Education and Research · 2015
- B7-H1 antibodies and method of use63US 8,460,927 B2Mayo Foundation for Medical Education and Research · 2013
- Isolated B7-H4 specific compositions and methods of use thereof45US 9,422,351 B2The Trustees of the University of Pennsylvania · 2016